BRIEF published on 12/17/2024 at 08:05, 4 days 7 hours ago Ondine Biomedical Begins US Phase 3 Clinical Trial FDA Approval Healthcare Innovation Ondine Biomedical Clinical Trial Nasal Photodisinfection
PRESS RELEASE published on 12/17/2024 at 08:00, 4 days 7 hours ago Ondine Commencing US Phase 3 Clinical Trial Ondine Biomedical Inc. announces the start of Phase 3 clinical trial for its nasal photodisinfection technology, Steriwave, with FDA approval. Trial conducted in collaboration with HCA Healthcare Steriwave Ondine Biomedical Phase 3 Trial HCA Healthcare Nasal Photodisinfection
BRIEF published on 10/28/2024 at 08:05, 1 month 24 days ago Ondine Biomedical Advances Steriwave Commercialization Antimicrobial Resistance Ondine Biomedical Steriwave Technology Healthcare-associated Infections Innovation In Healthcare
PRESS RELEASE published on 10/28/2024 at 08:00, 1 month 24 days ago Ondine Continues Commercial Growth Ondine Biomedical Inc. provides updates on the commercial roll-out of its Steriwave® nasal decolonization technology, reducing healthcare-associated infections with light-activated treatment Ondine Biomedical Inc. Nasal Decolonization Steriwave Healthcare-associated Infections Antimicrobial Treatments
BRIEF published on 10/23/2024 at 08:05, 1 month 29 days ago Ondine Biomedical Inc. Launches Steriwave Pilot at King's College Hospital Steriwave Healthcare Innovation Ondine Biomedical Antimicrobial Treatment King's College Hospital
PRESS RELEASE published on 10/23/2024 at 08:00, 1 month 29 days ago Ondine Biomedical Inc. Announces King's College Hospital to Run Steriwave Pilot Ondine Biomedical Inc. collaborates with King's College Hospital to pilot Steriwave® light-activated antimicrobial tech for preventing HAIs. Steriwave rapidly eliminates pathogens without resistance Ondine Biomedical Inc. Steriwave Hospital-acquired Infections Antimicrobial Technology King's College Hospital
BRIEF published on 09/30/2024 at 11:10, 2 months 21 days ago Ondine Biomedical Reports Robust Growth in H1 2024 Clinical Trials Steriwave Ondine Biomedical Financial Growth Hospital Adoption
PRESS RELEASE published on 09/30/2024 at 11:05, 2 months 21 days ago Ondine Biomedical Reports Robust Growth in H1 2024 Ondine Biomedical Inc. reports unaudited operational and financial results for the first half of 2024, showing strong revenue growth and strategic partnerships Financial Performance Ondine Biomedical Inc. Strategic Partnership Clinical Trials Operational Results
BRIEF published on 09/30/2024 at 08:05, 2 months 21 days ago Ondine Biomedical Reports Robust Growth in H1 2024 Financial Results Clinical Trials Ondine Biomedical Steriwave® H1 2024
PRESS RELEASE published on 09/30/2024 at 08:00, 2 months 21 days ago Ondine Biomedical Reports Robust Growth in H1 2024 Ondine Biomedical reports unaudited strong operational and financial results for the first half of 2024, including revenue growth and strategic partnerships Financial Results Strategic Partnership Ondine Biomedical Operational Highlights Clinical Endeavors
Published on 12/21/2024 at 01:30, 14 hours 16 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 16 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 15 hours 41 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 16 hours 16 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 14 hours 54 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 15 hours 1 minute ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 35 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 20 hours 50 minutes ago CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 21 hours 46 minutes ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 3 hours 28 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 21 hours 46 minutes ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 21 hours 51 minutes ago Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 1 hour ago Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 21 hours ago Share capital decrease by way of treasury shares cancellation
